Aktie 1035 BBI LIFE SCIENCES CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen BBI Life Sciences Corporation

Aktien

1035

KYG1089Y1180

1035

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
LJ Future Ltd completed the acquisition of 43.3% stake in BBI Life Sciences Corporation.
BBI Life Sciences Corporation Appoints Liu Bin as a Non-Executive Director, Effective April 18, 2020
BBI Life Sciences Corporation Did Not Recommend the Payment of A Final Dividend for the Year Ended December 31, 2019
Bbi Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2019
LJ Future Ltd made a proposal to acquire 43.3% stake in BBI Life Sciences Corporation for approximately HKD 850 million.
Bbi Life Sciences Corporation Reports Earnings Results for the Half Year Ended June 30, 2019
BBI Life Sciences Corporation Recommends Final Dividend for the Year Ended December 31, 2018, Payable on 31 July 2019
Bbi Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2018
BBI Life Sciences Corporation Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018
BBI Life Sciences Corporation Provides Group Profit Guidance for the Six Months Ended June 30, 2018
BBI Life Sciences Corporation Approves Final Dividend for the Year Ended 31 December 2017, Payable on or Around 31 July 2018
BBI Life Sciences Corporation Announces Change of Principal Place of Business in Hong Kong
BBI Life Sciences Corporation Announces Board Changes
BBI Life Sciences Corporation Recommends Final Dividend for the Year Ended 31 December 2017, Payable on 31 July 2018
BBI Life Sciences Corporation Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017
BBI Life Sciences Corporation Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017
Bbi Life Sciences : Monthly Return on Movements in Securities for the month ended 31/07/2017
Bbi Life Sciences : Monthly Return on Movements in Securities for the month ended 30/06/2017
BBI Life Sciences Corporation Proposes Final Dividend for the Year Ended December 31, 2016, Payable on June 30, 2017
BBI Life Sciences Corporation Reports Audited Consolidated Capital Expenditure Results for the Year Ended December 31, 2016
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 1035 Aktie
  4. Nachrichten BBI Life Sciences Corporation
  5. Andere Sprachen